Clinical Pharmacokinetics of Sirolimus
- 1 January 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 40 (8), 573-585
- https://doi.org/10.2165/00003088-200140080-00002
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The Pharmacokinetics of Extended‐Release Formulations of Calcium Antagonists and of Amlodipine in Subjects with Different Gastrointestinal Transit TimesThe Journal of Clinical Pharmacology, 1999
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- Pharmacokinetics of Prednisolone During Administration of Sirolimus in Patients with Renal TransplantsThe Journal of Clinical Pharmacology, 1996
- EFFECTS OF THE PHARMACOKINETIC INTERACTION BETWEEN ORALLY ADMINISTERED SIROLIMUS AND CYCLOSPORINE ON THE SYNERGISTIC PROLONGATION OF HEART ALLOGRAFT SURVIVAL IN RATS1Transplantation, 1996
- Inhibition by Rapamycin of P‐Glycoprotein 170‐Mediated Export from Normal LymphocytesScandinavian Journal of Immunology, 1996
- Rapamycin: Distribution, Pharmacokinetics, and Therapeutic Range InvestigationsTherapeutic Drug Monitoring, 1995
- Prolongation Of Renal Allograft Survival In A Large Animal Model By Oral Rapamycin MonotherapyTransplantation, 1995
- Blood Distribution Of RapamycinTransplantation, 1993
- PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCINTransplantation, 1991
- THE REJECTION OF RENAL HOMOGRAFTSThe Lancet, 1960